Susann Handrick

Dr. Susann Handrick


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
BDBoubacar Diallo
Boubacar Diallo
DSDaouda Sissoko
Daouda Sissoko
NLNicholas J. Loman
Nicholas J. Loman
HBHadja Aïssatou Bah
Hadja Aïssatou Bah
HBHawa Bah
Hawa Bah
SDSophie Duraffour
Sophie Duraffour
We report on an Ebola virus disease (EVD) survivor who showed Ebola virus in seminal fluid 531 days after onset of disease. The persisting virus was sexually transmitted in February 2016, about 470 days after onset of symptoms, and caused a new cluster of EVD in Guinea and Liberia.

29 March 2013 in ACS Chemical Biology
Verified
Journal Article
Closed access
SNSofie Nyström
Sofie Nyström
KPKatarzyna M. Psonka-Antonczyk
Katarzyna M. Psonka-Antonczyk
PEPål Gunnar Ellingsen
Pål Gunnar Ellingsen
LJLeif B. G. Johansson
Leif B. G. Johansson
NRNina Reitan
Nina Reitan
KNK. Peter R. Nilsson
K. Peter R. Nilsson

1 September 2011 in Journal of Virology
Verified
Journal Article
Closed access
MMM. Marklewitz
M. Marklewitz
SHSusann Handrick
Susann Handrick
WGW. Grasse
W. Grasse
AKA. Kurth
A. Kurth
ALAlexander Lukashev
Alexander Lukashev
SJSandra Junglen
Sandra Junglen
The family Bunyaviridae is the most diversified family of RNA viruses. We describe a novel prototypic bunyavirus, tentatively named Gouléako virus, isolated from various mosquito species trapped in Côte d'Ivoire. The S segment comprised 1,087 nucleotides (nt), the M segment 3,188 nt, and the L segment 6,358 nt, constituting the shortest bunyavirus genome known so far. The virus had shorter genome termini than phleboviruses and showed no evidence of encoded NSs and NSm proteins. An uncharacterized 105-amino-acid (aa) putative open reading frame (ORF) was detected in the S segment. Genetic equidistance to other bunyaviruses (74 to 88% aa identity) and absence of serological cross-reactivity with phleboviruses suggested a proposed novel Bunyaviridae genus.

12 October 2015 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SPStefan Prokop
Stefan Prokop
KMKelly R. Miller
Kelly R. Miller
NDNatalia Drost
Natalia Drost
SHSusann Handrick
Susann Handrick
VMVidhu Mathur
Vidhu Mathur
FHFrank L. Heppner
Frank L. Heppner
Although central nervous system–resident microglia are believed to be ineffective at phagocytosing and clearing amyloid-β (Aβ), a major pathological hallmark of Alzheimer’s disease (AD), it has been suggested that peripheral myeloid cells constitute a heterogeneous cell population with greater Aβ-clearing capabilities. Here, we demonstrate that the conditional ablation of resident microglia in CD11b-HSVTK (TK) mice is followed by a rapid repopulation of the brain by peripherally derived myeloid cells. We used this system to directly assess the ability of peripheral macrophages to reduce Aβ plaque pathology and therefore depleted and replaced the pool of resident microglia with peripherally derived myeloid cells in Aβ-carrying APPPS1 mice crossed to TK mice (APPPS1;TK). Despite a nearly complete exchange of resident microglia with peripheral myeloid cells, there was no significant change in Aβ burden or APP processing in APPPS1;TK mice. Importantly, however, newly recruited peripheral myeloid cells failed to cluster around Aβ deposits. Even additional anti-Aβ antibody treatment aimed at engaging myeloid cells with amyloid plaques neither directed peripherally derived myeloid cells to amyloid plaques nor altered Aβ burden. These data demonstrate that mere recruitment of peripheral myeloid cells to the brain is insufficient in substantially clearing Aβ burden and suggest that specific additional triggers appear to be required to exploit the full potential of myeloid cell–based therapies for AD.

1 March 2019 in European Journal of Microbiology and Immunology
Verified
Journal Article
Open access
HKHans Kollenda
Hans Kollenda
HFHagen Frickmann
Hagen Frickmann
RHRania Ben Helal
Rania Ben Helal
DWDorothea Franziska Wiemer
Dorothea Franziska Wiemer
HNHabiba Naija
Habiba Naija
MMMohamed Ben Moussa
Mohamed Ben Moussa
Background: Carbapenem-resistance is frequently detected in Enterobacteriaceae isolated from patients in Tunisia. The study was performed to identify frequent carbapenemases in Tunisian isolates. Methods: Between May 2014 and January 2018, 197 ertapenem-resistant Enterobacteriaceae were isolated at the microbiological department of the Military Hospital of Tunis. The strains were phenotypically characterized and then subjected to in-house polymerase chain reaction (PCR) targeting the carbapenemase genes blaIMP, blaVIM, blaNDM, blaSPM, blaAIM, blaDIM, blaGIM, blaSIM, blaKPC, blaBIC, and blaOXA-48. Results: The assessed 197 ertapenem-resistant Enterobacteriaceae from Tunis comprised 170 Klebsiella pneumoniae, 19 Enterobacter cloacae, 6 Escherichia coli, 1 Citrobacter sedlakii, and 1 Enterobacter asburiae. Thereby, 55 out of 197 isolates (27.9%) were from blood cultures, suggesting a systemic disease. The carbapenemase gene blaOXA-48 quantitatively dominated by far with 153 detections, followed by blaNDM with 14 detections, which were distributed about the whole study interval. In contrast, blaBIC and blaVIM were only infrequently identified in 5 and 3 cases, respectively, while the other carbapenamases were not observed. Conclusions: The carbapenemase gene blaOXA-48 was identified in the vast majority of ertapenem-resistant Tunisian Enterobacteriaceae while all other assessed carbapenemases were much less abundant. In a quantitatively relevant minority of isolates, the applied PCR-based screening approach did not identify any carbapenemases.

9 October 2020 in Virus Genes
Verified
Journal Article
Open access
PDF file
SHSusann Handrick
Susann Handrick
MBMalena Bestehorn-Willmann
Malena Bestehorn-Willmann
SESimone Eckstein
Simone Eckstein
MWMathias C. Walter
Mathias C. Walter
MAMarkus H. Antwerpen
Markus H. Antwerpen
MMMohamed Ben Moussa
Mohamed Ben Moussa
In the present work, two complete genome sequences of SARS-CoV-2 were obtained from nasal swab samples of Tunisian SARS-CoV-2 PCR-positive patients using nanopore sequencing. The virus genomes of two of the patients examined, a Tunisian soldier returning from a mission in Morocco and a member of another Tunisian family, showed significant differences in analyses of the total genome and single nucleotide polymorphisms (SNPs). Phylogenetic relationships with known SARS-CoV-2 genomes in the African region, some European and Middle Eastern countries and initial epidemiological conclusions indicate that the introduction of SARS-CoV-2 into Tunisia from two independent sources was travel-related.